More Business Wire
View Older Stories View Newer Stories-
BGC Reports Third Quarter 2025 Financial Results
-
DefEYE, Inc. Announces Investment from ExSight Ventures
-
Alcoa, Ball and Unilever Partner to Launch the First Use of ELYSIS® Carbon-Free Smelting Technology in Consumer Personal and Home Care Packaging
-
Destiny Tech100 Inc. Reports Third Quarter 2025 Results
-
Utz Brands to Webcast Presentation at the Stephens Annual Investment Conference on November 18
-
Avallon Secures $4.6 Million, Scales AI Agents to Automate Insurance Claims Operations
-
Bain Capital Partners with Restaurant Executive Steve Ritchie to Launch Prosper Growth Partners, New Franchise Platform
-
SkyMirr’s Sky5G™ Router Named CES 2026 Innovation Awards® Honoree
-
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
-
Safanad’s Chief Strategist, Dr. John Rutledge, “Redefines Investing” With Launch of Asset-First Economics Video Series
-
Peraton Executives Named Among 2025 FORUM IT100 Awardees
-
Montai Therapeutics Presents Preclinical Data on NRF2 Agonist in Ulcerative Colitis at ACAAI Annual Meeting
-
FIS Achieves Exclusive Category Leader Recognition Across All Quadrants in Chartis Credit Risk Management Report
-
QAD | Redzone Appoints Rajeev Purohit as General Manager, India and Head of Engineering for ERP & Supply Chain
-
Sempresto and Health Alliance Global Partner to Develop a Smart Communication Platform Integrating Patientside Diagnostics and Virtual Care with Rescue Medication Delivery
-
Team Cymru Launches RADAR to Provide Instant Infrastructure Visibility to Cyber Defenders
-
Valley Bank Appoints Matthew Verney Chief Banking Officer for Philadelphia Region
-
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
-
Brown-Forman Second Quarter Earnings Release and Conference Call Scheduled for December 4, 2025
-
AEye Expands Apollo Manufacturing Capacity to 60,000 Units, Bolstered by a Globally Recognized Institutional Investor
-
Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technology
-
Organ Recovery Systems Announces NEJM Publication of Landmark Follow Up 10-Year Kidney Study Comparing LifePort® Hypothermic Machine Perfusion to Static Cold Storage
-
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart
-
Worldwide Clinical Trials Appoints John Capicchioni as Senior Vice President, Commercial, Early Phase
-
Nordson Corporation Announces Earnings Release and Webcast for Fourth Quarter and Fiscal Year 2025
-
Quantum to Announce Fiscal Second Quarter 2026 Financial Results on Thursday, November 13, 2025
-
Debiopharm Takes a Step Forward for Children With CPP: Enrollment Completion for the Phase III Trial Evaluating the First Ever Yearly Injectable Triptorelin Formulation
-
mPulse Delivers Strong Q3 Results, Gains Forrester Recognition, and Makes C-Suite Appointment
-
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
-
Allergy Partners Appoints William A. McCann, M.D. as Chief Executive Officer
-
Holiday Hills Returns to STACKT market with a Modern Twist on Holiday Nostalgia
-
Target RWE Announces Upcoming Presentations at AASLD – The Liver Meeting 2025
-
Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year”
-
Brighthouse Financial Cancels Conference Call to Discuss Third Quarter 2025 Results and Provides Select Preliminary Financial Results
-
Aquarian Capital to Acquire Brighthouse Financial
-
Physicians of Southwest Washington and Remo Health Launch Innovative Dementia Care Partnership
-
Priority Technology Holdings, Inc. Reports Third Quarter Financial Results
-
Soluna Announces Monthly Business Update
-
Cummins Reports Strong Third Quarter Operating Results, Records Non-Cash Charges Related to its Electrolyzer Business
-
SelectQuote, Inc. Reports First Quarter of Fiscal Year 2026 Results
-
Tradeweb Reports October 2025 Total Trading Volume of $65.4 Trillion and Average Daily Volume of $2.8 Trillion
-
NUBURU Strengthens Balance Sheet, Advances Defense-Tech Acquisition Program and Revamps Blue-Laser Business
-
Neurogene Announces First Participant Dosed in Embolden™ Registrational Trial of NGN-401 Gene Therapy for Rett Syndrome
-
NETSCOUT Reports Second Quarter Fiscal Year 2026 Financial Results
-
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025
-
NextNav Inc. Reports Third Quarter 2025 Results and Operational Highlights
-
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
-
Madison Square Garden Entertainment Corp. Reports Fiscal 2026 First Quarter Results
-
BIOVECTRA and Revolution Biomanufacturing Partner to Deliver Integrated mRNA Design and GMP Production Services
